Delivery Order SPE2DR25D3004-SPE2DR26FXRC4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of NUCYNTA ER 100 mg tablets (60-count units) valued at $2,850.28 with firm fixed pricing. The contract is non-set-aside and competitively awarded, with an ultimate completion date of December 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,137.68 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a competitive procurement with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and...
- The Defense Logistics Agency awarded a $2,334.68 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units). This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $1 billion through December 2026. The award utilized firm fixed pricing with no set-aside designation, reflecting competitive procurement through open competition....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,941.77 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 200 mg tablets (60-count units) on August 29, 2025, with a completion date of September 2, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $2,137.68 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by December 19, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The order represents a child action under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $1,425.14. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $2,850.28 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $2,761.93. This non-set-aside delivery order represents a competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 22, 2025. The order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NUCYNTA ER 100 mg tablets (60-count) with a ceiling value of $2,084.56. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of...
- The Defense Logistics Agency awarded a delivery order valued at $4,416.12 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXRC4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,305.56 to AmerisourceBergen Drug Corp for the supply of NUCYNTA ER 100 mg tablets (60-count units) with an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's primary IDC vehicle with DLA Troop Support Medical (SPE2DX), a $999.999 billion indefinite delivery contract extending through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide. The contract vehicle encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and other critical medical commodities across multiple therapeutic domains. AmerisourceBergen's consistent performance on federal pharmaceutical contracts, demonstrated through numerous competitive awards with firm fixed pricing, reflects its established capability to meet the Defense Logistics Agency's stringent medical supply requirements for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/17/25 |